Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. ITL Asia Pacific Sdn Bhd
WARNING LETTER
•ITL Asia Pacific Sdn Bhd•May 30, 2019

ITL Asia Pacific Sdn Bhd – FDA Warning Letter, May 30, 2019

Record Details

The FDA issued a Warning Letter to Plot 17B, Lorong Bemban 2 Bemban Industrial Estate, Batu Gajah, Perak, Malaysia, following an inspection from May 27-30, 2019. The firm manufactures blood collection devices, specifically the SampLok System with Hinged Lid, which were found to be adulterated under 21 U.S.C. § 351(h) due to non-conformity with the Quality System regulation (21 CFR Part 820). The firm's response to the FDA 483 was deemed inadequate.

Key violations include: 1) Failure to establish and maintain adequate design control procedures (21 CFR 820.30(a)) for the Class II SampLok Luer Kit. 2) Inadequate corrective and preventive action (CAPA) procedures (21 CFR 820.100(a)), lacking identification of all quality data sources and statistical methodology. 3) Failure to validate processes not fully verifiable by inspection/test (21 CFR 820.75(a)), specifically the mixing process for the SampLok System. 4) Failure to establish and maintain procedures for validating device design (21 CFR 820.30(g)), evidenced by retesting rejected products at lower pressures. 5) Failure to maintain investigation records for customer complaints (21 CFR 820.198(e)). 6) Devices were also misbranded due to failure to adequately develop, maintain, and implement written Medical Device Reporting (MDR) procedures (21 CFR 803.17).

The FDA requires the firm to provide a written response within fifteen business days detailing specific corrective actions, prevention plans, and a timetable for implementation. Failure to correct these violations will result in continued refusal of admission for devices into the U.S. (detention without physical examination) and potential impact on federal contracts and premarket approvals.

Company
ITL Asia Pacific Sdn Bhd
Inspection date
May 30, 2019
Product type
Devices
Office
Office of Health Technology 3 (Gastrorenal, ObGyn, General Hospital, and Urology Devices)
People
  • Benjamin R. Fisher (Office Director)
  • Susan Finneran
View Company Profile

ID · 4e5b68fb-7892-4d56-be4f-0ba204bdd7c4

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.30(a)21 CFR 820.100(a)21 CFR 820.75(a)21 CFR 820.30(g)21 CFR 820.19821 CFR 820.198(a)21 CFR 820.198(e)

Full citation text and observation details available on the Dashboard.

Other documents for ITL Asia Pacific Sdn Bhd
  • 483 - 2019-05-30May 30, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore ITL Asia Pacific Sdn Bhd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.